Avotil may be available in the countries listed below.
Prochlorperazine maleate (a derivative of Prochlorperazine) is reported as an ingredient of Avotil in the following countries:
International Drug Name Search
Ridauran may be available in the countries listed below.
Auranofin is reported as an ingredient of Ridauran in the following countries:
International Drug Name Search
Cardisorb may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Cardisorb in the following countries:
International Drug Name Search
Penicilline G Sodique may be available in the countries listed below.
Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicilline G Sodique in the following countries:
International Drug Name Search
Cortes may be available in the countries listed below.
Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Cortes in the following countries:
International Drug Name Search
Pirorheum may be available in the countries listed below.
Piroxicam is reported as an ingredient of Pirorheum in the following countries:
International Drug Name Search
Fuviron may be available in the countries listed below.
Aciclovir is reported as an ingredient of Fuviron in the following countries:
International Drug Name Search
Gynoxin may be available in the countries listed below.
Fenticonazole nitrate (a derivative of Fenticonazole) is reported as an ingredient of Gynoxin in the following countries:
International Drug Name Search
Lamotrigina EG may be available in the countries listed below.
Lamotrigine is reported as an ingredient of Lamotrigina EG in the following countries:
International Drug Name Search
ATP Kyowa may be available in the countries listed below.
Adenosine Triphosphate disodium salt (a derivative of Adenosine Triphosphate) is reported as an ingredient of ATP Kyowa in the following countries:
International Drug Name Search
Acido Ascorbico Bayer may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Acido Ascorbico Bayer in the following countries:
International Drug Name Search
Azanin may be available in the countries listed below.
Azathioprine is reported as an ingredient of Azanin in the following countries:
International Drug Name Search
Carbosylane may be available in the countries listed below.
Charcoal, Activated is reported as an ingredient of Carbosylane in the following countries:
Dimeticone is reported as an ingredient of Carbosylane in the following countries:
Simeticone is reported as an ingredient of Carbosylane in the following countries:
International Drug Name Search
Ranitidins may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidins in the following countries:
International Drug Name Search
Pantoprazole Isomed may be available in the countries listed below.
Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantoprazole Isomed in the following countries:
International Drug Name Search
In the US, Forteo (teriparatide systemic) is a member of the drug class parathyroid hormone and analogs and is used to treat Osteoporosis.
US matches:
Teriparatide is reported as an ingredient of Forteo in the following countries:
International Drug Name Search
Fem-Mono Retard may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Fem-Mono Retard in the following countries:
International Drug Name Search
Indocollirio may be available in the countries listed below.
Indometacin is reported as an ingredient of Indocollirio in the following countries:
International Drug Name Search
Periocline may be available in the countries listed below.
Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Periocline in the following countries:
International Drug Name Search
Abiplatin may be available in the countries listed below.
Cisplatin is reported as an ingredient of Abiplatin in the following countries:
International Drug Name Search
Aciclovir Pharmagenus may be available in the countries listed below.
Aciclovir is reported as an ingredient of Aciclovir Pharmagenus in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Ivermectin is reported as an ingredient of Equimectrin in the following countries:
International Drug Name Search
Aclarubicin Hydrochloride may be available in the countries listed below.
Aclarubicin Hydrochloride (BANM) is also known as Aclarubicin (Rec.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Kamadol may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Kamadol in the following countries:
International Drug Name Search
Propranolol-CT may be available in the countries listed below.
Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol-CT in the following countries:
International Drug Name Search
Fluoxetina Sumol may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Sumol in the following countries:
International Drug Name Search
Pretir may be available in the countries listed below.
Azithromycin is reported as an ingredient of Pretir in the following countries:
International Drug Name Search
Fenobarbital Richmond may be available in the countries listed below.
Phenobarbital is reported as an ingredient of Fenobarbital Richmond in the following countries:
Phenobarbital sodium salt (a derivative of Phenobarbital) is reported as an ingredient of Fenobarbital Richmond in the following countries:
International Drug Name Search
Foliferron may be available in the countries listed below.
Ferrous Fumarate is reported as an ingredient of Foliferron in the following countries:
Folic Acid is reported as an ingredient of Foliferron in the following countries:
International Drug Name Search
Camezol may be available in the countries listed below.
Metronidazole is reported as an ingredient of Camezol in the following countries:
International Drug Name Search
Relifex 500 mg Film-coated Tablets
Each tablet contains 500 mg nabumetone.
For a full list of excipients, see section 6.1.
Dark red, film-coated tablets marked Relifex on one side and "500" on the other.
Nabumetone is a non-acidic non-steroidal anti-inflammatory agent which is a relatively weak inhibitor of prostaglandin synthesis. However, following absorption from the gastrointestinal tract it is rapidly metabolised in the liver to the principal active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA), a potent inhibitor of prostaglandin synthesis.
It is indicated for the treatment of osteoarthritis and rheumatoid arthritis requiring anti-inflammatory and analgesic treatment.
For oral administration.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).
Relifex 500 mg film-coated tablets should be taken preferably with or after food.
Adults
The recommended daily dose is two tablets (1 g) taken as a single dose at bedtime.
For severe or persistent symptoms, or during acute exacerbations, an additional one or two tablets (500 mg-1 g) may be given as a morning dose.
Elderly
In common with many drugs, blood levels may be higher in elderly patients. The recommended daily dose of two tablets (1 g) should not be exceeded in this age group and in some cases one tablet (500 mg) may give satisfactory relief.
The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patients should be monitored for gastrointestinal bleeding during NSAID therapy.
Children
There are no clinical data to recommend use of Relifex in children.
Hypersensitivity to nabumetone or to any of the excipients.
Active, or history of recurrent peptic ulcer/ haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
NSAID's are contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin or other non-steroidal anti-inflammatory drugs.
Severe heart failure, hepatic failure and renal failure (see section 4.4).
During the last trimester of pregnancy (see section 4.6).
History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and gastrointestinal and cardiovascular risks below).
The use of Relifex with concomitant NSAIDs, including cyclooxygenase-2 selective inhibitors should be avoided (see section 4.5).
Elderly
The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2).
Respiratory Disorders:
Caution is required if administered to patients suffering from, or with a previous history of, bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such patients.
Cardiovascular Renal and Hepatic Impairment:
The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. In patients with impaired renal function (creatinine clearance less than 30 ml/minute), dosage reduction should be considered. Renal function should be monitored in these patients (see also section 4.3).
Cardiovascular and cerebrovascular effects:
Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.
Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long term treatment) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). There are insufficient data to exclude such a risk for nabumetone.
Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with nabumetone after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking).
Gastrointestinal bleeding, ulceration and perforation:
GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or a previous history of serious GI events.
The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients required concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and section 4.5).
Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.
Caution should be advised in patients received concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anti-coagulants such as warfarin, selective serotonin re-uptake inhibitors or anti-platelet agents such as aspirin (see section 4.5).
When GI bleeding or ulceration occurs in patients receiving nabumetone, the treatment should be withdrawn.
NSAIDS should be given with care to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn's disease) as these conditions may be exacerbated (see section 4.8).
SLE and mixed connective tissue disease:
In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders, there may be an increased risk of aseptic meningitis (see section 4.8).
Dermatological:
Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy; the onset of the reaction occurring in the majority of cases within the first month of treatment. Relifex should be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity.
Impaired female fertility
The use of Relifex may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Relifex should be considered.
Other analgesics including cyclooxygenase-2 selective inhibitors: avoid the concomitant use of two or more NSAIDs (including aspirin) as this may increase the risk of adverse effects (see section 4.4).
Anti-hypertensives: Reduced anti-hypertensive effect.
Diuretics: Reduced diuretic effect. Diuretics can increase the risk of nephrotoxicity of NSAIDs.
Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.
Lithium: Decreased elimination of lithium.
Methotrexate: Decreased elimination of methotrexate.
Ciclosporin: Increased risk of nephrotoxicity.
Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.
Corticosteroids: Increased risk of gastrointestinal ulceration or bleeding (see section 4.4).
Anti-coagulants: NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see section 4.4).
Quinolone antibiotics: Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.
Anti-platelet agents and selective serotonin reuptake inhibitors (SSRI's): Increased risk of gastrointestinal bleeding (see section 4.4).
Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.
Zidovudine: Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk of haemarthroses and heamatoma in HIV(+) haemophiliacs receiving concurrent treatment with Zidovudine and ibuprofen.
Pregnancy:
Congenital abnormalities have been reported in association with NSAID administration in man; however these are low in frequency and do not appear to follow any discernible pattern. In view of the known effects of NSAIDs on the foetal cardiovascular system (risk of closure of the ductus ateriosus), use in the last trimester of pregnancy is contraindicated. The onset of labour may be delayed and the duration increased with an increased bleeding tendency in both mother and child (see section 4.3). NSAIDs should not be used during the first two trimesters of pregnancy or labour unless the potential benefit to the patient outweighs the potential risk to the foetus.
Lactation:
In limited studies so far available, NSAIDs can appear in breast milk in very low concentrations. NSAIDs should, if possible, be avoided when breastfeeding.
See section 4.4 Special warnings and precautions for use, regarding female fertility.
Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.
Gastrointestinal: The most commonly-observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly may occur. Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of Crohn's disease (see section 4.4) have been reported following administration. Less frequently, gastritis has been observed. Pancreatitis has been reported very rarely. (See section 4.4).
Hypersensitivity: Hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of (a) non-specific allergic reactions and anaphylaxis (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angiodema and, more rarely exfoliative and bullous dermatoses (including epidermal necrolysis and erythema multiforme).
Cardiovascular and cerebrovascular: Oedema, hypertension, and cardiac failure, have been reported in association with NSAID treatment.
Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long term treatment) may be associated with an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4).
Other adverse reactions reported less commonly include:
Renal: Nephrotoxicity in various forms, including interstitial nephritis, nephrotic syndrome and renal failure.
Hepatic: Abnormal liver function, hepatitis and jaundice.
Neurological and special senses: Visual disturbances, optic neuritis, headaches, paraesthesia, reports of aseptic meningitis (especially in patients with existing autoimmune disorders such as systemic lupus erythematosus, mixed connective tissue disease), with symptoms such as stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4), depression, confusion, hallucinations, tinnitus, vertigo, dizziness, malaise, fatigue and drowsiness.
Haematological: Thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia and haemolytic anaemia.
Dermatological: Bullous reactions including Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (very rare). Photosensitivity.
a) Symptoms: Symptoms include headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, rarely diarrhoea, disorientation, excitation, coma, drowsiness, dizziness, tinnitus, fainting and occasionally convulsions. In cases of significant poisoning acute renal failure and liver damage are possible.
b) Therapeutic measure: Patients should be treated symptomatically as required. Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered. Alternatively, in adults, gastric lavage should be considered within one hour of ingestion of a potentially life threatening overdose. Good urine output should be ensured. Renal and liver function should be closely monitored. Patients should be observed for at least four hours after ingestion of potentially toxic amounts. Frequent or prolonged convulsions should be treated with intravenous diazepam. Other measures may be indicated by the patients clinical condition.
ATC Code: M01AX01
Nabumetone is a non-acidic non-steroidal anti-inflammatory agent which is a relatively weak inhibitor of prostaglandin synthesis. A notable feature of the animal pharmacology is the lack of effect on the gastric mucosa. Following absorption from the gastrointestinal tract nabumetone is rapidly metabolised in the liver to the principal active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) a potent inhibitor of prostaglandin synthesis.
Although nabumetone is absorbed essentially intact through the small intestine, extensive metabolism occurs during the first pass through the liver. As a result, concentrations in plasma of nabumetone are barely detectable after oral dosage. Intravenous studies in rats with nabumetone indicate it to be rapidly distributed throughout the body, in keeping with its highly lipophilic character. The active metabolite, 6-MNA, binds strongly to plasma proteins; it is distributed into inflamed tissue and crosses the placenta into foetal tissue. It is found in the milk of lactating females. 6-MNA is eliminated by metabolism, principally conjugation with glucuronic acid, and o-demethylation followed by conjugation, the main route of excretion being the urine. The plasma elimination half-life is about 1 day in man.
Not applicable.
Sodium starch glycollate
Sodium lauryl sulphate
Hydroxypropylmethylcellulose (E464)
Magnesium stearate (E572)
Microcrystalline cellulose (E460)
Red carmine (E120)
Yellow iron oxide (E172)
Titanium dioxide (E171)
Talc (E553b)
Polyethylene glycol
Saccharin sodium (E954)
Liquid caramel flavour
Purified water
Carnauba wax (E903)
Not applicable.
36 months.
Keep the tablets in the original carton in order to protect from light.
HDPE bottles each containing 56 tablets.
None.
Meda Pharmaceuticals Ltd
249 West George Street
Glasgow
G2 4RB
Trading as:
Meda Pharmaceuticals Ltd.
Skyway House
Parsonage Road
Takeley
Bishop's Stortford
CM22 6PU
UK
PL 15142/0106
Date of first Authorisation: 15 March 1984
Date of last Renewal: 14th March 2007
29th October 2009
In the US, Acetohydroxamic Acid (acetohydroxamic acid systemic) is a member of the drug class miscellaneous genitourinary tract agents and is used to treat Bladder Infection and Urinary Tract Infection.
US matches:
Rec.INN
G04BX03
0000546-88-3
C2-H5-N-O2
75
Enzyme inhibitor, urease
Acetamide, N-hydroxy-
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Amoxicilina Richet may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Richet in the following countries:
International Drug Name Search
Tolmicil may be available in the countries listed below.
Tolciclate is reported as an ingredient of Tolmicil in the following countries:
International Drug Name Search
Propranolol Helvepharm may be available in the countries listed below.
Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol Helvepharm in the following countries:
International Drug Name Search
Aprednislon may be available in the countries listed below.
Prednisolone is reported as an ingredient of Aprednislon in the following countries:
International Drug Name Search
Fluconazole Qualimed may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazole Qualimed in the following countries:
International Drug Name Search
Apo-Chlorax may be available in the countries listed below.
Chlordiazepoxide is reported as an ingredient of Apo-Chlorax in the following countries:
Chlordiazepoxide hydrochloride (a derivative of Chlordiazepoxide) is reported as an ingredient of Apo-Chlorax in the following countries:
Clidinium Bromide is reported as an ingredient of Apo-Chlorax in the following countries:
International Drug Name Search
In the US, Alosetron (alosetron systemic) is a member of the drug class serotoninergic neuroenteric modulators and is used to treat Diarrhea and Irritable Bowel Syndrome.
US matches:
Rec.INN
A03AE01
0122852-42-0
C17-H18-N4-O
294
Antiemetic
Serotonin antagonist
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one (WHO)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Broxal may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Broxal in the following countries:
International Drug Name Search
Panadol 7+ years may be available in the countries listed below.
Paracetamol is reported as an ingredient of Panadol 7+ years in the following countries:
International Drug Name Search
Tecnosal may be available in the countries listed below.
Triflusal is reported as an ingredient of Tecnosal in the following countries:
International Drug Name Search
Terbinafine Merck may be available in the countries listed below.
Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafine Merck in the following countries:
International Drug Name Search
Tebesium TRIO may be available in the countries listed below.
Isoniazid is reported as an ingredient of Tebesium TRIO in the following countries:
Pyrazinamide is reported as an ingredient of Tebesium TRIO in the following countries:
Rifampicin is reported as an ingredient of Tebesium TRIO in the following countries:
International Drug Name Search
Procaine-Stella may be available in the countries listed below.
Procaine hydrochloride (a derivative of Procaine) is reported as an ingredient of Procaine-Stella in the following countries:
International Drug Name Search
H.G. Griseofulvin may be available in the countries listed below.
Griseofulvin is reported as an ingredient of H.G. Griseofulvin in the following countries:
International Drug Name Search
Rifamax may be available in the countries listed below.
Rifampicin is reported as an ingredient of Rifamax in the following countries:
International Drug Name Search
Risolid may be available in the countries listed below.
Chlordiazepoxide is reported as an ingredient of Risolid in the following countries:
International Drug Name Search
Azymol may be available in the countries listed below.
Aripiprazole is reported as an ingredient of Azymol in the following countries:
International Drug Name Search
Moklar may be available in the countries listed below.
Moclobemide is reported as an ingredient of Moklar in the following countries:
International Drug Name Search
Malugel may be available in the countries listed below.
Aluminium Hydroxide is reported as an ingredient of Malugel in the following countries:
Calcium Carbonate is reported as an ingredient of Malugel in the following countries:
Magnesium Trisilicate is reported as an ingredient of Malugel in the following countries:
Simeticone is reported as an ingredient of Malugel in the following countries:
International Drug Name Search
Blesifen may be available in the countries listed below.
Clomifene citrate (a derivative of Clomifene) is reported as an ingredient of Blesifen in the following countries:
International Drug Name Search
Fada Diclofenac may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Fada Diclofenac in the following countries:
International Drug Name Search
Afpred-DEXA may be available in the countries listed below.
Dexamethasone 21-(sodium 3-sulfobenzoate) (a derivative of Dexamethasone) is reported as an ingredient of Afpred-DEXA in the following countries:
International Drug Name Search
Flecainid Hexal may be available in the countries listed below.
Flecainide acetate (a derivative of Flecainide) is reported as an ingredient of Flecainid Hexal in the following countries:
International Drug Name Search
In the US, Aerobid-M (flunisolide systemic) is a member of the drug class inhaled corticosteroids and is used to treat Asthma.
US matches:
Flunisolide is reported as an ingredient of Aerobid-M in the following countries:
International Drug Name Search
Kolestran may be available in the countries listed below.
Colestyramine is reported as an ingredient of Kolestran in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of R Pen in the following countries:
International Drug Name Search
Kezol may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Kezol in the following countries:
International Drug Name Search
Gabapentina Cantabria may be available in the countries listed below.
Gabapentin is reported as an ingredient of Gabapentina Cantabria in the following countries:
International Drug Name Search
Adrin may be available in the countries listed below.
Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Adrin in the following countries:
International Drug Name Search
Fosteofos may be available in the countries listed below.
Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Fosteofos in the following countries:
International Drug Name Search
Piridoksinas L may be available in the countries listed below.
Pyridoxine is reported as an ingredient of Piridoksinas L in the following countries:
International Drug Name Search
Bionicard may be available in the countries listed below.
Nicardipine hydrochloride (a derivative of Nicardipine) is reported as an ingredient of Bionicard in the following countries:
International Drug Name Search
Cetihexal may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetihexal in the following countries:
International Drug Name Search
Resoferon may be available in the countries listed below.
Ferrous Sulfate is reported as an ingredient of Resoferon in the following countries:
International Drug Name Search
Clotrimanova may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Clotrimanova in the following countries:
International Drug Name Search
Methohexital sodium salt (a derivative of Methohexital) is reported as an ingredient of Brevital in the following countries:
International Drug Name Search
Paclitaxel Hospira may be available in the countries listed below.
Paclitaxel is reported as an ingredient of Paclitaxel Hospira in the following countries:
International Drug Name Search
Eukaptil may be available in the countries listed below.
Captopril is reported as an ingredient of Eukaptil in the following countries:
International Drug Name Search
Carbocaïne may be available in the countries listed below.
Mepivacaine hydrochloride (a derivative of Mepivacaine) is reported as an ingredient of Carbocaïne in the following countries:
International Drug Name Search
Cloviran may be available in the countries listed below.
Aciclovir is reported as an ingredient of Cloviran in the following countries:
International Drug Name Search
Bisoprolol AbZ may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol AbZ in the following countries:
International Drug Name Search
Idracemi Eparina may be available in the countries listed below.
Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Idracemi Eparina in the following countries:
Hydrocortisone 21-(disodium phosphate) (a derivative of Hydrocortisone) is reported as an ingredient of Idracemi Eparina in the following countries:
International Drug Name Search
Glutide may be available in the countries listed below.
Glutathione is reported as an ingredient of Glutide in the following countries:
International Drug Name Search
Hjertemin may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Hjertemin in the following countries:
International Drug Name Search
Azithromycin Hexal may be available in the countries listed below.
Azithromycin is reported as an ingredient of Azithromycin Hexal in the following countries:
Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin Hexal in the following countries:
Azithromycin monohydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin Hexal in the following countries:
International Drug Name Search
Merck-Ciprofloxacine may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Merck-Ciprofloxacine in the following countries:
International Drug Name Search
Folivital may be available in the countries listed below.
Folic Acid is reported as an ingredient of Folivital in the following countries:
International Drug Name Search
Finasterida Ortrodol may be available in the countries listed below.
Finasteride is reported as an ingredient of Finasterida Ortrodol in the following countries:
International Drug Name Search
Ferridex may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Iron Dextran is reported as an ingredient of Ferridex in the following countries:
International Drug Name Search
Bicalutamide Arrow may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Bicalutamide Arrow in the following countries:
International Drug Name Search
Thyrotardin may be available in the countries listed below.
Liothyronine is reported as an ingredient of Thyrotardin in the following countries:
International Drug Name Search
BTX-HA may be available in the countries listed below.
Betaxolol hydrochloride (a derivative of Betaxolol) is reported as an ingredient of BTX-HA in the following countries:
International Drug Name Search
In the US, Busulfex (busulfan systemic) is a member of the drug class alkylating agents and is used to treat Bone Marrow Transplantation, Chronic Myelogenous Leukemia and Thrombocythemia.
US matches:
Busulfan is reported as an ingredient of Busulfex in the following countries:
International Drug Name Search
Aminoglutetimid may be available in the countries listed below.
Aminoglutethimide is reported as an ingredient of Aminoglutetimid in the following countries:
International Drug Name Search
Gomec may be available in the countries listed below.
Omeprazole is reported as an ingredient of Gomec in the following countries:
International Drug Name Search
Micoskin may be available in the countries listed below.
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Micoskin in the following countries:
International Drug Name Search
Apo-Ketotifen may be available in the countries listed below.
Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Apo-Ketotifen in the following countries:
International Drug Name Search
AHP may be available in the countries listed below.
Oxaceprol is reported as an ingredient of AHP in the following countries:
International Drug Name Search
Adenoject may be available in the countries listed below.
Adenosine is reported as an ingredient of Adenoject in the following countries:
International Drug Name Search
Freederm Zink may be available in the countries listed below.
Pyrithione Zinc is reported as an ingredient of Freederm Zink in the following countries:
International Drug Name Search
Acébutolol Ranbaxy may be available in the countries listed below.
Acebutolol hydrochloride (a derivative of Acebutolol) is reported as an ingredient of Acébutolol Ranbaxy in the following countries:
International Drug Name Search
Agulan may be available in the countries listed below.
Perindopril is reported as an ingredient of Agulan in the following countries:
Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Agulan in the following countries:
International Drug Name Search
Finigas may be available in the countries listed below.
Dimeticone is reported as an ingredient of Finigas in the following countries:
International Drug Name Search
Losartan Potasico Latina may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Potasico Latina in the following countries:
International Drug Name Search
Emitex may be available in the countries listed below.
Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Emitex in the following countries:
International Drug Name Search
Guardian may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ivermectin is reported as an ingredient of Guardian in the following countries:
Moxidectin is reported as an ingredient of Guardian in the following countries:
Praziquantel is reported as an ingredient of Guardian in the following countries:
Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Guardian in the following countries:
International Drug Name Search
Mirax may be available in the countries listed below.
Domperidone is reported as an ingredient of Mirax in the following countries:
International Drug Name Search
Falimint may be available in the countries listed below.
Acetylaminonitropropoxybenzene is reported as an ingredient of Falimint in the following countries:
International Drug Name Search
Losartan Almus may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Almus in the following countries:
International Drug Name Search
Fentanilo Acostlabs may be available in the countries listed below.
Fentanyl is reported as an ingredient of Fentanilo Acostlabs in the following countries:
International Drug Name Search
Coforin may be available in the countries listed below.
Pentostatin is reported as an ingredient of Coforin in the following countries:
International Drug Name Search
Rec.INN
R07AA01
0000063-89-8
C40-H80-N-O8-P
734
Drug acting on the respiratory system
Choline hydroxide, dihydrogen phosphate, inner salt, ester with L-1,2-dipalmitin
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Betahistine-IPS may be available in the countries listed below.
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Betahistine-IPS in the following countries:
International Drug Name Search
Rifadecina may be available in the countries listed below.
Rifampicin is reported as an ingredient of Rifadecina in the following countries:
International Drug Name Search
Esprocy may be available in the countries listed below.
Cyproheptadine is reported as an ingredient of Esprocy in the following countries:
International Drug Name Search
Perphenazine Zhaohui may be available in the countries listed below.
Perphenazine is reported as an ingredient of Perphenazine Zhaohui in the following countries:
International Drug Name Search
Indafon Retard may be available in the countries listed below.
Indapamide is reported as an ingredient of Indafon Retard in the following countries:
International Drug Name Search
Cordinate plus may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Cordinate plus in the following countries:
Valsartan is reported as an ingredient of Cordinate plus in the following countries:
International Drug Name Search
